Third member of prestigious FDA panel resigns over approval of Biogen’s Alzheimer’s drug

Visits: 2

A third member of a key FDA panel has resigned over the agency’s controversial decision to approve Biogen’s new Alzheimer’s drug, Aduhelm, CNBC has learned. Read More Go To Source